A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATOR¿CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FARICIMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (TENAYA)
Research Grant
Administered By
Ophthalmology
Awarded By
Genentech, Inc.
Start Date
December 3, 2018
End Date
March 31, 2024
Administered By
Ophthalmology
Awarded By
Genentech, Inc.
Start Date
December 3, 2018
End Date
March 31, 2024